Literature DB >> 10452668

Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir.

O Benveniste1, P Longuet, X Duval, V Le Moing, C Leport, J L Vildé.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452668     DOI: 10.1086/517777

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

Review 1.  Indinavir: a review of its use in the management of HIV infection.

Authors:  G L Plosker; S Noble
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

Review 2.  HIV-associated immune complex kidney disease.

Authors:  Ehsan Nobakht; Scott D Cohen; Avi Z Rosenberg; Paul L Kimmel
Journal:  Nat Rev Nephrol       Date:  2016-01-19       Impact factor: 28.314

Review 3.  Ritonavir-induced acute kidney injury: kidney biopsy findings and review of literature.

Authors:  T Shafi; M J Choi; L C Racusen; L A Spacek; C Berry; M Atta; D M Fine
Journal:  Clin Nephrol       Date:  2011-02       Impact factor: 0.975

Review 4.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 5.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

Review 6.  Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.

Authors:  Milena M McLaughlin; Aimee J Guerrero; Andrew Merker
Journal:  Drugs Context       Date:  2018-03-21

7.  SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases.

Authors:  Tai-Nin Chau; Kam-Cheong Lee; Hung Yao; Tak-Yin Tsang; Tat-Chong Chow; Yiu-Cheong Yeung; Kin-Wing Choi; Yuk-Keung Tso; Terence Lau; Sik-To Lai; Ching-Lung Lai
Journal:  Hepatology       Date:  2004-02       Impact factor: 17.425

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.